ALKERMES | ALKS - 营业费用

股票价格

35.02

每天变化

0.25 0.72%

每月一次

26.24%

每年

31.70%

Q2 预测

33.76

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.63B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	营业费用	更改		日
AbbVie	USD 10.81B		13.45B	2025-12
Acadia Pharmaceuticals	USD 266.6M		23.72M	2025-12
ALKERMES	USD 326.44M		1.41B	2025-12
Amgen	USD 5.9B		773M	2025-12
Biogen	USD 1.88B		81.4M	2025-09
BioMarin Pharmaceutical	USD 676.18M		131.65M	2025-12
Bristol-Myers Squibb	USD 8.3B		10.25B	2025-12
Coherus Biosciences	USD 51.83M		2.48M	2025-12
Eli Lilly	USD 10.31B		1.09B	2025-12
Gilead Sciences	USD 4.96B		707M	2025-12
Heron Therapeutics	USD 40.55M		1.46M	2025-12
Ionis Pharmaceuticals	USD 418M		101.1M	2025-12
J&J	USD 18.97B		2.38B	2025-12
Malin Corporation	EUR 1.1M		400K	2024-12
Merck	USD 10.16B		558M	2025-12
Minerva Neurosciences	USD 4.52M		155.46K	2024-12
Nektar Therapeutics	USD 40.9M		44.19M	2025-12
Neurocrine Biosciences	USD 577.6M		22M	2025-12
Otsuka Holdings	JPY 582.9B		113.74B	2025-12
Ovoca Bio	EUR 1.16M		4.48M	2025-06
Pfizer	USD 12.91B		79.89B	2025-12
Regeneron Pharmaceuticals	USD 2.99B		27.97B	2025-12
Vertex Pharmaceuticals	USD 1.93B		89.1M	2025-12